1-A Offering Statement – CFN Media

Algernon Pharmaceuticals Forms Private Subsidiary to Advance Company’s Psychedelic DMT Stroke Program; Files Form 1-A Offering Statement with U.S. SEC for Regulation A+ Offering

Psychedelic Drug DMT – Stroke Treatment Trial VANCOUVER, British Columbia, Jan. 03,…

Ryan Allway
January 3, 2023

Don Kreski

Robin Lefferts

Ryan Allway

Ryan has been a financial writer for more than a decade, covering…

Investing in Plastic Recycling Technology

Plastic waste is widely recognized as a major problem that needs to…

Robin Lefferts
November 21, 2024

Cardiol’s Favorable Phase 2 Results Set the Table for Advanced Clinical Trials

Cardiol Therapeutics Inc. (Nasdaq: CRDL) (TSX: CRDL) recently presented excellent…

Robin Lefferts
November 20, 2024

Aduro Clean Technologies Engages Global Leader Zeton for Design and Fabrication of Hydrochemolytic™ Pilot Plant

Milestone Project to Demonstrate Aduro’s Modular, Scalable Solution for Converting…

Ryan Allway
November 19, 2024

IKE Tech LLC and Ispire Technology Inc. Announce Positive Pre-PMTA Submission Meeting with the FDA

Seeks Authorization for Pioneering Point-of-Use Identity and Age Verification…

Ryan Allway
November 18, 2024